WISHLIST.RU biolabs

Страницы: 1 ... 52 53 54 55 56 57 58 ... 70 (697)

все | 1 1018 12 1541 19a 2 2019 208b 2a 3 328 3d 4 405 430 468 488 499 4_antibody 5 514 532 542 565 580 590 594 6 610 620 633 635p 643 647 647n a2 aa abberior ace2 activated acyclovir acyclovir for coronavirus adcc adcc-enhanced_anti-il12 adenocarcinoma adenosine adenovirus adjuvant adjuvants adme aestivum agarose aggregation ah50 aided alexa alpaca alpha alternative alzheimer analogue analogues analysis and animal anti anti-mica antibdy antibodie antibodies antibody antigen antisense antiviral application applications aptamer are artery asparagine assay assays assessment asthma astrovirus atlizumab atp9a atpaf1 atpaf2 atpase atpif1 atr atrazine atrip atrn attack atto avant avi azauridine b b3 bacterial banking based bcx4430 beads best beta between bi biacore bimekizumab binding binning bioassays for bispecific antibody biobetter biochemistry biochips biofluids biology biomarker bioprint bispecific bleomycin blocking antibodies that neutralize egf in the extracellular space bn1205_064130 br bsab btn3a3 bub1 by c c1248f c3 c3ar c4b c5ar cab cancer canine capture car cardiovascular carry casq2 casz1 cat cct6b cd40 cd40l cdc cdr cedelizumab cel cela1 cela3a cela3b celf1 celf2 celf4 celf6 cell cells cellular cerebral ch100 chain characterization chemical chemokines chimeras chimeric chip chloroquine chromosome cmv cns cntln cofactor coi complement complex component computer conjugate coronavirus cov cow coxsackievirus cpg cr3022 cra cruzi cry crystallography csra ctla ctrp2 ctsa ctss custom cycs cyp2c18 cyp2d6 cyp51a1 cytokine cytomegalovirus cytotoxicity d d2 d3 d614g d63 daf danlos darby database deamidation degradation dengue denv denv1 dependent design detection develop developability developed development diagnostic diagnostics difference dimensional disadvantages discovery disease display dll4 dna do domain double droplet drug dux3 dux4 dvl2 dvl3 dydc1 dydc2 dykddddk e e2 e3 e6 ebola ebv ebv_gh efficacy efna1 efna4 efnb2 egf egfl6 egfl7 egfr ehlers eif3m elegans endocytosis enhanced enhancement enrichment env envelope enzyme eomes epitope ertumaxomab erythematosus eso etaratuzumab etrolizumab evaluation events evinacumab evolocumab exbivirumab exosome expansion express expressed expression extract extraction f f1 factor family fanolesomab faralimomab fc fc engineering for aglycosylated antibody fc engineering for serum half life regulation (ph sensitivity) fcm feeder fgfr3 fgfr4 fibrin fibrinogen fibroblast ficolin finger firbosis fkn flavivirus fluor fragment free function functional functionality fusion g g476s gag gagp17 gagp24 galidesivir gamma gammadelta gb gd gene gene therapy for genetic hearing loss gene therapy for vision disorder generation generic genetic genetics genome gfp gh girentuximab gl_antibody glomerulopathy gluc glucl glycoprotein glycyrrhizin gmp gondii gp120 gp160 gp24 gp41 gpg growth gst guinea h h146y h49y h519q h655y halotag hantaan hapten hbsag hcv hdm health hepatitis her2 herpes herpesvirus herv hiv hla homologue homology how how is a vaccine developed how was the yellow fever vaccine developed hpiv hpn hpse hpv hpv16e7 hpv59 hpv6 hpv69 hras hrsv hsa hsg hsp90aa2p hsp90b1 hspa9 hsv hsv1 htlv human humanised humanized humans hybrid hybridoma hydroxycytidine ia icam1 icam3 icos identification igg ii il il-23_biobetter il1 il11ra il12rb1 il13 imciromab immune immunomodulation in indium indomethacin induced inebilizumab infection inflammation infliximab influenza influenza a virus antibody influenzae inhibitor inhibitors inhibitory inolimomab inotuzumab interaction interfering internalization intestinalis intestine intetumumab io iodine ipf ips ipsc is isdb isolation ivd ixekizumab j j1 j2 japonica k kidney killed kit l l1 labeling laminin lamp large lentiviral lesion liability library ligand ligase like line linker live llama loop lps lupus lyophilized m m164 m2 m45 mab mac madin marker masp2 mcmv mdck mdm2 measurement mediated medication melanogaster melanoma membrane mers mesothelin mesothelioma mhc micb_antibody microfluidic middle minute mir mirna mm1 mode model modeling models modification modifications molecular molecule monitoring monoclonal mouse mr mrna mucin16 multiple mumps mut mutagenesis myeloma n n4 nc ncdv ncov nectin1 nef neuraminidase neuroblastoma neutab neutralizing newcastle next nhp nim nitd008 np ns1 ns3 ns4b ns5b nuclease nucleoprotein nucleoside ny occlusion of ohda oligonucleotide ompa on oncolytic oncolytic virotherapy with il-2 oncolytic virus therapy with cytokine oncolytic virus therapy with hepo ophthalmology optimization organism organisms osteosarcoma ov with dsred ov with egfp ov with gfp ova ovarian ozogamicin p18 p24 p53 pa pancreatic parkinson particle parva pathway pbp pcdna3 pcr peptide perakizumab periodontal periostin permeability pg phagocytosis phd phosphospecific pig pk plasmid plga polymerase polyplexes polyprotein post potency prediction preparation priliximab proadm production profiling program prolamin protac protein proteins proteolysis pulmonary purification quantifying quantitation ra rabbit rabies rat ray receptor recognition recombinant red region regression release remdesivir retroviral reverse rhinovirus rna rodent rotavirus rt rt-pcr for coronavirus ruplizumab s s1 s2 s884f safety sars sb290157 sbp scfv screening sdab sea secondary secukinumab self sepsis sequence sequencing serine serology service services sev severe shark short sialidases silico simplex single sirna sirp situ siv siy size slc30a8 small solubility specific sphingomyelins spike spr stability staphylococcal star steap1 stem stk15 structural structure study subunit sudv sumoylation sur46 sur9 survivin3a sv40 syndrome syngeneic system systemic systems systhesis syt9 t t. aestivum prolamin a-ii mhc tetramer t240i t29i t323i t768i t791i tachykinin tacr2 tag tamiflu target targeting tas1r2 tas2r14 tas2r16 tat tax tcr tcts technology teneliximab teplizumab test testing tetramer tggt1_223680 the classical pathway therapeutic therapy three tnfsf14 tool toralizumab toxicity tp03_0849 tralokinumab transgene translational trop2 troponin trps tumor two ubiquitin ubiquitination ul1 ul27 unilateral urotensin v1230l v367f vaccine vaccines vaccinia variable vdbp vector vegf vhh viracept virotherapy virus viruses vitamin vitro vivo vlp vp1 vp35 vsp what what is a hapten what is hepatitis a virus antibody whole wnv work x yeast zanolimumab zeocin zfns zolgensma

C5aR complement

c5ar complement

https://www.creative-biolabs....

2020-08-17 19:38
C5aR complement from Creative Biolabs. With more than a decade of exploration and development, Creative Biolabs offers a full range of one-stop services for Complement Therapeutics. In addition, our project procedure can be totally designed to meet y
... дальше

MASP2 therapeutic

masp2 therapeutic

https://www.creative-biolabs....

2020-08-17 19:38
MASP2 therapeutic from Creative Biolabs. With more than a decade of exploration and development, Creative Biolabs offers a full range of one-stop services for Complement Therapeutics. In addition, our project procedure can be totally designed to meet
... дальше

membrane cofactor protein complement

https://www.creative-biolabs....

2020-08-17 19:37
membrane cofactor protein complement from Creative Biolabs. With more than a decade of exploration and development, Creative Biolabs offers a full range of one-stop services for Complement Therapeutics. In addition, our project procedure can be total
... дальше

DAF complement

daf complement

https://www.creative-biolabs....

2020-08-17 19:37
DAF complement from Creative Biolabs. With more than a decade of exploration and development, Creative Biolabs offers a full range of one-stop services for Complement Therapeutics. In addition, our project procedure can be totally designed to meet yo
... дальше

MAC-inhibitory protein complement

mac inhibitory protein complement

https://www.creative-biolabs....

2020-08-17 19:37
MAC-inhibitory protein complement from Creative Biolabs. With more than a decade of exploration and development, Creative Biolabs offers a full range of one-stop services for Complement Therapeutics. In addition, our project procedure can be totally
... дальше

shark antibody

https://www.creative-biolabs....

2020-08-17 19:37
With years of research and development experience in antibody discovery, scientists of Creative Biolabs have developed the Native™ Antibody Discovery Platform to generate monoclonal antibody with native and in vivo characteristics. This proprietary p
... дальше

service rat

https://www.creative-biolabs....

2020-08-17 19:36
Using our exclusive antigen-specific B lymphocytes cytometry technology, Creative Biolabs has built the unique Native™ Antibody Discovery Platform. This proprietary platform can serve our clients with high-throughput discovery of native rat antibodie
... дальше

service rabbit

https://www.creative-biolabs....

2020-08-17 19:36
Creative Biolabs offers the exclusive Native™ Antibody Discovery technology for custom development of high affinity and specific native rabbit monoclonal antibodies. Through this proprietary technology, a large scale of candidate antibodies of native
... дальше

in situ mutagenesis

https://www.creative-biolabs....

2020-08-17 19:36
The proven expertise of Creative Biolabs’s team in the field of in vitro mutagenesis combined with our optimized technology allows us to deliver mutated and verified vectors (purified DNA and bacterial clones) within only a few days, thereby saving s
... дальше

hybridoma antibodies

https://www.creative-biolabs....

2020-08-17 19:35
Creative Biolabs provides rat and mouse monoclonal antibodies construction services. In particular, our proprietary mouse immunization approach allows us to provide mouse monoclonal antibodies within 100 days.

Страницы: 1 ... 52 53 54 55 56 57 58 ... 70 (697)

Biolabs_marketing

C5aR complement

MASP2 therapeutic

membrane cofactor protein complement

DAF complement

MAC-inhibitory protein complement

shark antibody

service rat

service rabbit

in situ mutagenesis

hybridoma antibodies

Напишите ваши желания